HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Yttrium-86

Also Known As:

86Y radioisotope; Y-86 radioisotope

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Aluicio-Sarduy, Eduardo: 1 article (01/2021)
2.	Anderson, Bryce R: 1 article (01/2021)
3.	Arthur, Ian S: 1 article (01/2021)
4.	Barnhart, Todd E: 1 article (01/2021)
5.	Bates, Amber M: 1 article (01/2021)
6.	Bednarz, Bryan P: 1 article (01/2021)
7.	Chakravarty, Ishan: 1 article (01/2021)
8.	Clark, Paul A: 1 article (01/2021)
9.	Engle, Jonathan W: 1 article (01/2021)
10.	Grudzinski, Joseph J: 1 article (01/2021)

Related Diseases

1.	Neoplasms (Cancer) 01/01/2021 - "Yttrium-86 (86Y) chelated to NM600 was delivered intravenously by tail vein to mice harboring flank and brain melanoma tumors, and PET imaging demonstrated specific accumulation up to 72 h at each tumor site (∼12:1 brain tumor/brain and ∼8:1 flank tumor/muscle). "
2.	Melanoma (Melanoma, Malignant) 01/01/2021 - "Yttrium-86 (86Y) chelated to NM600 was delivered intravenously by tail vein to mice harboring flank and brain melanoma tumors, and PET imaging demonstrated specific accumulation up to 72 h at each tumor site (∼12:1 brain tumor/brain and ∼8:1 flank tumor/muscle). "
3.	Brain Neoplasms (Brain Tumor) 01/01/2021 - "Yttrium-86 (86Y) chelated to NM600 was delivered intravenously by tail vein to mice harboring flank and brain melanoma tumors, and PET imaging demonstrated specific accumulation up to 72 h at each tumor site (∼12:1 brain tumor/brain and ∼8:1 flank tumor/muscle). "